Skip to content
MedHelpChina
EN English
TreatmentsHospitalsServices & pricingGuidesFree assessment

CAR-T cell therapy

Autologous cell therapy for relapsed or refractory lymphoma and multiple myeloma at leading haematology centres.

Updated: November 12, 2026
Reference cost in China

USD 48,000

Typical stay

3–4 weeks

Waiting time

2–3 weeks

0
Direct access to public-hospital specialists

Start your confidential assessment

Describe the patient’s condition and upload recent imaging and records. Your medical advisor replies within 1 business day with a first assessment and specialist availability.

Submit records for review Encrypted transfer · No hidden fees for the assessment

Medical information disclaimer

Clinical information and cost ranges on this page are for guidance and initial planning only, not a prescription or diagnosis. The final treatment and rehabilitation plan is decided by the treating chief physician after examination and imaging.